Clinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, China.
Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, China.
Cancer Biol Ther. 2024 Dec 31;25(1):2398285. doi: 10.1080/15384047.2024.2398285. Epub 2024 Sep 5.
Breast cancer stands as the most prevalent cancer diagnosed worldwide, often leading to brain metastasis, a challenging complication characterized by high mortality rates and a grim prognosis. Understanding the intricate mechanisms governing breast cancer brain metastasis (BCBM) remains an ongoing challenge. The unique microenvironment in the brain fosters an ideal setting for the colonization of breast cancer cells. The tumor microenvironment (TME) in brain metastases plays a pivotal role in the initiation and progression of BCBM, shaping the landscape for targeted therapeutic interventions. Current research primarily concentrates on unraveling the complexities of the TME in BCBM, with a particular emphasis on neuroglia and immune cells, such as microglia, monocyte-derived macrophages (MDMs), astrocytes and T cells. This comprehensive review delves deeply into these elements within the TME of BCBM, shedding light on their interplay, mechanisms, and potential as therapeutic targets to combat BCBM.
乳腺癌是全球最常见的癌症诊断类型,常导致脑转移,这是一种具有高死亡率和严峻预后的挑战性并发症。深入理解乳腺癌脑转移(BCBM)的复杂机制仍然是一个持续的挑战。大脑中独特的微环境为乳腺癌细胞的定植提供了理想的条件。脑转移中的肿瘤微环境(TME)在 BCBM 的起始和进展中起着关键作用,为靶向治疗干预塑造了景观。目前的研究主要集中在揭示 BCBM 中 TME 的复杂性,特别关注神经胶质和免疫细胞,如小胶质细胞、单核细胞衍生的巨噬细胞(MDMs)、星形胶质细胞和 T 细胞。本综述深入探讨了 BCBM 中 TME 的这些元素,揭示了它们的相互作用、机制以及作为治疗靶点对抗 BCBM 的潜力。